FDA’s UDI Draft Rule Details Device Marking, Database Submission Mandates
This article was originally published in The Gray Sheet
Executive Summary
The long-anticipated proposal maps out a unique device identifier system that FDA says will be crucial to the future of post-market safety surveillance, recall management and safety alerts. The effort also will help reduce medical errors and bring an array of other benefits, stakeholders say.
You may also be interested in...
Device Industry Seeks Attention At Upcoming U.S.-Europe Trade Talks
U.S. and EU device trade groups make the case to government officials for addressing device regulatory harmonization as part of planned Transatlantic Trade and Investment Partnership negotiations.
Washington Roundup, February 2013
The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.”
Regulatory News In Brief
FDA issues draft-guidance on accreditation of third-party reviewers for 510(k)s and final guidance for surgical ablation devices. More regulatory news.